6505--Mesalamine 1200mg Tablet (VA-27-00000768)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0025

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Mesalamine 1200mg Tablets under procurement identifier 36E79726R0025. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating a focus on pharmaceutical products. The primary objective of this procurement is to secure a reliable supply of Mesalamine 1200mg Tablets, a medication commonly used in the treatment of inflammatory bowel diseases such as ulcerative colitis. The intended outcome is to ensure that VA healthcare facilities have consistent access to this essential medication, thereby supporting the ongoing healthcare needs of veterans nationwide. The scope of this contract encompasses the manufacturing and delivery of Mesalamine 1200mg Tablets in accordance with VA specifications and quality standards. Contractors are expected to provide products that meet all applicable regulatory requirements for pharmaceutical manufacturing, including FDA approval and compliance with Good Manufacturing Practices (GMP). The deliverables include timely and accurate fulfillment of orders for the specified medication, ensuring product integrity and patient safety throughout the contract lifecycle. The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this procurement is Youlanda Duggar, who can be reached via email at [email protected] or by phone at 708-786-4943. The notice remains active as of the posting date, September 15, 2026, and further details, including any attachments, can be accessed through the official SAM.gov opportunity listing at https://sam.gov/opp/b13a4440cbcf4aac9d3e74a46c809b05/view. This procurement is classified as an award notice, indicating that the contract has already been awarded. There is no information provided regarding set-aside requirements or special considerations such as small business preferences or socioeconomic program participation. Contractors interested in similar future opportunities should ensure they are capable of meeting the stringent regulatory and quality requirements associated with pharmaceutical manufacturing for federal healthcare agencies. In summary, this award supports the VA’s mission to provide high-quality healthcare to veterans by ensuring the availability of critical pharmaceutical products. The contract is managed by a dedicated federal office with clear points of contact, and it requires adherence to industry standards and federal regulations throughout the duration of the agreement.